These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 27017954)

  • 1. Glycosylation pattern of anti-platelet IgG is stable during pregnancy and predicts clinical outcome in alloimmune thrombocytopenia.
    Sonneveld ME; Natunen S; Sainio S; Koeleman CA; Holst S; Dekkers G; Koelewijn J; Partanen J; van der Schoot CE; Wuhrer M; Vidarsson G
    Br J Haematol; 2016 Jul; 174(2):310-20. PubMed ID: 27017954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prominent lack of IgG1-Fc fucosylation of platelet alloantibodies in pregnancy.
    Kapur R; Kustiawan I; Vestrheim A; Koeleman CA; Visser R; Einarsdottir HK; Porcelijn L; Jackson D; Kumpel B; Deelder AM; Blank D; Skogen B; Killie MK; Michaelsen TE; de Haas M; Rispens T; van der Schoot CE; Wuhrer M; Vidarsson G
    Blood; 2014 Jan; 123(4):471-80. PubMed ID: 24243971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular surface plasmon resonance-based detection of anti-HPA-1a antibody glycosylation in fetal and neonatal alloimmune thrombocytopenia.
    Szittner Z; Bentlage AEH; Temming AR; Schmidt DE; Visser R; Lissenberg-Thunnissen S; Mok JY; van Esch WJE; Sonneveld ME; de Graaf EL; Wuhrer M; Porcelijn L; de Haas M; van der Schoot CE; Vidarsson G
    Front Immunol; 2023; 14():1225603. PubMed ID: 37868955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fetal and Neonatal Alloimmune Thrombocytopenia-New Prospects for Fetal Risk Assessment of HPA-1a-Negative Pregnant Women.
    Kjeldsen-Kragh J; Bengtsson J
    Transfus Med Rev; 2020 Oct; 34(4):270-276. PubMed ID: 33039264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics of human platelet antigen (HPA)-1a and HPA-5b alloimmunised pregnancies and the association between platelet HPA-5b antibodies and symptomatic fetal neonatal alloimmune thrombocytopenia.
    de Vos TW; Porcelijn L; Hofstede-van Egmond S; Pajkrt E; Oepkes D; Lopriore E; van der Schoot CE; Winkelhorst D; de Haas M
    Br J Haematol; 2021 Nov; 195(4):595-603. PubMed ID: 34402048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of HPA-1a alloantibody-mediated platelet destruction by a deglycosylated anti-HPA-1a monoclonal antibody in mice: toward targeted treatment of fetal-alloimmune thrombocytopenia.
    Bakchoul T; Greinacher A; Sachs UJ; Krautwurst A; Renz H; Harb H; Bein G; Newman PJ; Santoso S
    Blood; 2013 Jul; 122(3):321-7. PubMed ID: 23645838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Taking a wider view on fetal/neonatal alloimmune thrombocytopenia.
    Bonstein L; Haddad N
    Thromb Res; 2017 Mar; 151 Suppl 1():S100-S102. PubMed ID: 28262226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Core fucosylation and IgG function in NAIT.
    Aster RH
    Blood; 2014 Jan; 123(4):463-4. PubMed ID: 24458274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulated glycosylation patterns of IgG during alloimmune responses against human platelet antigens.
    Wuhrer M; Porcelijn L; Kapur R; Koeleman CA; Deelder A; de Haas M; Vidarsson G
    J Proteome Res; 2009 Feb; 8(2):450-6. PubMed ID: 18942870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting risk severity and response of fetal neonatal alloimmune thrombocytopenia.
    Salomon O; Rosenberg N
    Br J Haematol; 2013 Aug; 162(3):304-12. PubMed ID: 23672281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of human antibodies targeting human platelet antigen (HPA)-1a.
    Oosterhoff JJ; Linty F; Visser R; de Vos T; Hofstede-van Egmond S; van de Weerd M; Porcelijn L; de Haas M; van der Schoot E; Vidarsson G
    Transfusion; 2024 May; 64(5):893-905. PubMed ID: 38400657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal HPA-1a antibody level and its role in predicting the severity of Fetal/Neonatal Alloimmune Thrombocytopenia: a systematic review.
    Kjaer M; Bertrand G; Bakchoul T; Massey E; Baker JM; Lieberman L; Tanael S; Greinacher A; Murphy MF; Arnold DM; Baidya S; Bussel J; Hume H; Kaplan C; Oepkes D; Ryan G; Savoia H; Shehata N; Kjeldsen-Kragh J;
    Vox Sang; 2019 Jan; 114(1):79-94. PubMed ID: 30565711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Towards a prophylactic treatment of HPA-related foetal and neonatal alloimmune thrombocytopenia.
    Kjeldsen-Kragh J; Ni H; Skogen B
    Curr Opin Hematol; 2012 Nov; 19(6):469-74. PubMed ID: 22954726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toward a prophylaxis against fetal and neonatal alloimmune thrombocytopenia: induction of antibody-mediated immune suppression and prevention of severe clinical complications in a murine model.
    Tiller H; Killie MK; Chen P; Eksteen M; Husebekk A; Skogen B; Kjeldsen-Kragh J; Ni H
    Transfusion; 2012 Jul; 52(7):1446-57. PubMed ID: 22251227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies to develop a prophylaxis for the prevention of HPA-1a immunization and fetal and neonatal alloimmune thrombocytopenia.
    Kjær M; Geisen C; Akkök ÇA; Wikman A; Sachs U; Bussel JB; Nielsen K; Walles K; Curtis BR; Vidarsson G; Järås K; Skogen B
    Transfus Apher Sci; 2020 Feb; 59(1):102712. PubMed ID: 31948915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adding to the complexity of fetal and neonatal alloimmune thrombocytopenia: Reduced fibrinogen binding in the presence of anti-HPA-1a antibody and hypo-responsive neonatal platelets.
    Refsum E; Meinke S; Gryfelt G; Wikman A; Höglund P
    Thromb Res; 2018 Feb; 162():69-76. PubMed ID: 29306729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fetal and neonatal alloimmune thrombocytopenia: predictive factors of intracranial hemorrhage.
    Delbos F; Bertrand G; Croisille L; Ansart-Pirenne H; Bierling P; Kaplan C
    Transfusion; 2016 Jan; 56(1):59-66; quiz 58. PubMed ID: 26469867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal anti-platelet β3 integrins impair angiogenesis and cause intracranial hemorrhage.
    Yougbaré I; Lang S; Yang H; Chen P; Zhao X; Tai WS; Zdravic D; Vadasz B; Li C; Piran S; Marshall A; Zhu G; Tiller H; Killie MK; Boyd S; Leong-Poi H; Wen XY; Skogen B; Adamson SL; Freedman J; Ni H
    J Clin Invest; 2015 Apr; 125(4):1545-56. PubMed ID: 25774504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of Fetal/Neonatal Alloimmune Thrombocytopenia in Mice: Biochemical and Cell Biological Characterization of Isoforms of a Human Monoclonal Antibody.
    Mørtberg TV; Zhi H; Vidarsson G; Foss S; Lissenberg-Thunnissen S; Wuhrer M; Michaelsen TE; Skogen B; Stuge TB; Andersen JT; Newman PJ; Ahlen MT
    Immunohorizons; 2022 Jan; 6(1):90-103. PubMed ID: 35074850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alloantibody against new platelet alloantigen (Lap(a)) on glycoprotein IIb is responsible for a case of fetal and neonatal alloimmune thrombocytopenia.
    Wihadmadyatami H; Heidinger K; Röder L; Werth S; Giptner A; Hackstein H; Knorr M; Bein G; Sachs UJ; Santoso S
    Transfusion; 2015 Dec; 55(12):2920-9. PubMed ID: 26388194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.